Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
02 2020
Historique:
received: 23 10 2019
revised: 29 11 2019
accepted: 30 11 2019
pubmed: 21 1 2020
medline: 28 4 2021
entrez: 21 1 2020
Statut: ppublish

Résumé

Heart failure is a consequence of progression hypoxia-dependent tissue damages. Therapeutic approaches to restore and/or protect the healthy cardiac tissue have largely failed and remain a major challenge of regenerative medicine. The myo-inositol trispyrophosphate (ITPP) is a modifier of haemoglobin which enters the red blood cells and modifies the haemoglobin properties, allowing for easier and better delivery of oxygen by the blood. Here, we show that this treatment approach in an in vivo model of myocardial infarction (MI) results in an efficient protection from heart failure, and we demonstrate the recovery effect on post-MI left ventricular remodelling in the rat model. Cultured cardiomyocytes used to study the molecular mechanism of action of ITPP in vitro displayed the fast stimulation of HIF-1 upon hypoxic conditions. HIF-1 overexpression was prevented by ITPP when incorporated into red blood cells applied in a model of blood-perfused cardiomyocytes coupling the dynamic shear stress effect to the enhanced O

Identifiants

pubmed: 31957267
doi: 10.1111/jcmm.14909
pmc: PMC7011163
doi:

Substances chimiques

Hemoglobins 0
Inositol Phosphates 0
inositol trispyrophosphate 0
Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2272-2283

Informations de copyright

© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Références

J Am Coll Cardiol. 2005 Dec 6;46(11):2116-24
pubmed: 16325051
J Am Coll Cardiol. 2013 Aug 13;62(7):632-40
pubmed: 23644085
Am J Physiol. 1973 Mar;224(3):607-12
pubmed: 4691276
Circ Res. 2004 Jul 23;95(2):135-45
pubmed: 15271865
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1926-9
pubmed: 19204295
Chembiochem. 2010 Dec 10;11(18):2543-8
pubmed: 21086482
Am J Physiol. 1996 Oct;271(4 Pt 1):C1172-80
pubmed: 8897823
Antioxid Redox Signal. 2013 Mar 20;18(9):1009-20
pubmed: 22978600
Heart Fail Rev. 2020 Jan;25(1):53-65
pubmed: 31332663
Cell Mol Life Sci. 2019 May;76(9):1759-1777
pubmed: 30767037
Biochim Biophys Acta. 2011 Jul;1813(7):1360-72
pubmed: 20869993
N Engl J Med. 2009 Dec 17;361(25):2436-48
pubmed: 19920054
Mol Cell Biol. 1992 Dec;12(12):5447-54
pubmed: 1448077
J Mol Med (Berl). 2013 Jul;91(7):883-99
pubmed: 23471434
Circulation. 1996 Oct 15;94(8):1894-901
pubmed: 8873665
Cardiovasc Res. 2008 Jul 1;79(1):42-51
pubmed: 18310678
J Card Fail. 2014 Dec;20(12):905-11
pubmed: 25225112
Cardiovasc Res. 2012 Apr 1;94(1):77-86
pubmed: 22258630
Circulation. 2000 Nov 14;102(20 Suppl 4):IV14-23
pubmed: 11080127
Circ Res. 2015 Jun 19;117(1):65-79
pubmed: 26089364
Vascul Pharmacol. 2012 May-Jun;56(5-6):252-61
pubmed: 22446152
PLoS One. 2010 Jul 21;5(7):e11693
pubmed: 20657781
Eur J Heart Fail. 2017 Apr;19(4):469-478
pubmed: 27976514
Mol Cancer Ther. 2014 Jan;13(1):165-78
pubmed: 24170768
Bioorg Med Chem Lett. 2005 Mar 15;15(6):1605-8
pubmed: 15745806
J Cell Mol Med. 2020 Feb;24(3):2272-2283
pubmed: 31957267
Heart Fail Rev. 2016 Mar;21(2):213-21
pubmed: 26872672
Sci Rep. 2018 Oct 25;8(1):15758
pubmed: 30361476
Physiol Rev. 2019 Oct 1;99(4):1765-1817
pubmed: 31364924
Annu Rev Physiol. 2014;76:39-56
pubmed: 23988176
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1699-1708
pubmed: 30660522
Circulation. 1990 Apr;81(4):1161-72
pubmed: 2138525
N Engl J Med. 2013 Mar 28;368(13):1210-9
pubmed: 23473338
J Appl Physiol (1985). 1985 Jun;58(6):1810-7
pubmed: 4008402
Sci Rep. 2016 Apr 06;6:23756
pubmed: 27048757
Endothelium. 2002;9(4):247-61
pubmed: 12572856
Circulation. 2010 Sep 7;122(10):1004-16
pubmed: 20733101
J Am Coll Cardiol. 2002 Sep 18;40(6):1160-7; discussion 1168-71
pubmed: 12354444
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15576-81
pubmed: 17028170

Auteurs

Marta Oknińska (M)

Department of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Bouchra El-Hafny-Rahbi (B)

Center for Molecular Biophysics, UPR 4301 CNRS, Orleans, France.

Aleksandra Paterek (A)

Department of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Urszula Mackiewicz (U)

Department of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Claire Crola-Da Silva (C)

Center for Molecular Biophysics, UPR 4301 CNRS, Orleans, France.

Klaudia Brodaczewska (K)

Laboratory of Molecular Oncology and Innovative Therapies, MMI, Warsaw, Poland.

Michał Mączewski (M)

Department of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Claudine Kieda (C)

Center for Molecular Biophysics, UPR 4301 CNRS, Orleans, France.
Laboratory of Molecular Oncology and Innovative Therapies, MMI, Warsaw, Poland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH